BRANFORD, Conn., Nov. 1 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. (NASDAQ:CASM), a medical device company focused on innovative, non- invasive vital signs monitoring, today announced that the Company will release third quarter results for the period ended September 30, 2007 on Thursday, November 8, 2007 before the market opens. The Company will host a conference call that same morning at 10:00 a.m. Eastern Time. Participants on the call will be Andrew Kersey, President and CEO, and Jeffery Baird, CFO.

The live call may be accessed by phone at (888) 673-9809 (domestic) or (210) 234-0014 (international), passcode CASM. If you would like to participate, please call at least ten minutes prior to the start time of 10:00 a.m. Eastern Time. A replay of the call will also be available by phone until December 8, 2007 beginning approximately two hours after the end of the call. It can be accessed at (866) 458-4766 (domestic) or (203) 369-1322 (international).

A live audio webcast of the conference call will also be available at the Company's website located at www.casmed.com. Please allow extra time prior to the call to visit the site and download the streaming media software required to join the webcast. An online archive of the webcast will be available within two hours of the end of the live call and archived on the website until December 8, 2007.

About CAS

Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative, non-invasive technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include cerebral oximeters, blood pressure measurement technology, vital signs monitors, blood pressure cuffs, cardio-respiratory and apnea monitors and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.

    Company Contacts:
    CAS Medical Systems, Inc.
    Jeffery Baird, CFO
    203-488-6056
    ir@casmed.com

    FD
    John Capodanno
    212-850-5705
    john.capodanno@fd.com

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, and other risks detailed in the Company's Securities and Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate," "believe," "estimate," "expect," "may," "objective," "plan," "possible," "potential," "project," "will" and similar expressions identify forward- looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.

Source: CAS Medical Systems, Inc.